Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 6/20 | 0.50 |
| ▸ | FAAH | O00519 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.41 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31071117 | 0.84 | MGLL (0.44) | MGLLFAAHALDH1A1GAALMNA | |
| SCHEMBL7268279 | 0.83 | ALDH1A1 (0.43) | MGLLFAAHALDH1A1GAALMNA | |
| SCHEMBL15384106 | 0.83 | MGLL (0.41) | MGLLFAAHALDH1A1GAALMNA | |
| Hydrochloric Acid SCHEMBL11841772 | 0.79 | — | — | |
| SCHEMBL9427893 | 0.79 | — | — | |
| SCHEMBL1774032 | 0.79 | — | — | |
| SCHEMBL6530290 | 0.79 | — | — | |
| SCHEMBL16207638 | 0.76 | MGLL (0.56) | MGLLFAAHABHD6 | |
| SCHEMBL1414691 | 0.74 | — | — | |
| SCHEMBL12781912 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1540 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624129-B2 | Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking thereof | BMG PHARMA S.P.A. (IT) | 2026-05-12 | — | — | US | claimed |
| US-20250381259-A1 | Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof | PFIZER (US) | 2025-12-18 | — | — | US | claimed |
| EP-4661911-A1 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | Pfizer Inc. (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250281590-A1 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF | PFIZER (US) | 2025-09-11 | — | — | US | claimed |
| WO-2025133971-A1 | IMPROVED METHODS FOR PRODUCING BACTERIAL CAPSULAR SACCHARIDE GLYCOCONJUGATES | PFIZER INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250152693-A1 | Neisseria Meningitidis Vaccine | SANOFI PASTEUR INC. (US) | 2025-05-15 | — | — | US | claimed |
| CN-116162177-B | Inactivation method of modified starch and cyclododecatriene synthesis reaction solution | 万华化学集团股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-4463186-A1 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | Pfizer Inc. (US) | 2024-11-20 | — | — | EP | claimed |
| WO-2024166008-A1 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | PFIZER INC. (US) | 2024-08-15 | — | — | WO | claimed |
| WO-2024081372-A1 | PROCESSES FOR THE PREPARATION OF THE AGENT-LINKER CONJUGATE CL2A-SN-38 AND THE IMMUNOCONJUGATES SACITUZUMAB GOVITECAN AND LABETUZUMAB GOVETICAN | GILEAD SCIENCES, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| EP-0247725-B1 | Calcium independent camp phosphodiestrerase inhibitor antidepressant | PFIZER (US) | 1994-03-02 | — | — | EP | claimed |
| EP-0515510-A1 | HYDROQUINONE AMINO-ACID ESTERS, METHOD OF PREPARATION, AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM. | PANMEDICA SA (FR) | 1992-12-02 | — | — | EP | claimed |
| WO-1991011996-A1 | HYDROQUINONE AMINO-ACID ESTERS, METHOD OF PREPARATION, AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM | PANMEDICA (FR) | 1991-08-22 | — | — | WO | claimed |
| EP-0370382-A2 | Urea dipeptide derivatives with a renin-inhibiting activity, process to produce them, compositions containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-05-30 | — | — | EP | claimed |
| EP-0265495-A4 | BONDED PHASE CHROMATOGRAPHIC SUPPORTS. | ANALYTICHEM INT INC (US) | 1988-11-23 | — | — | EP | claimed |
| EP-0265495-A1 | BONDED PHASE CHROMATOGRAPHIC SUPPORTS | ANALYTICHEM INTERNATIONAL, INC. (US) | 1988-05-04 | — | — | EP | claimed |
| EP-0247725-A2 | Calcium independent camp phosphodiestrerase inhibitor antidepressant | PFIZER INC. (US) | 1987-12-02 | — | — | EP | claimed |
| WO-1987006586-A1 | BONDED PHASE CHROMATOGRAPHIC SUPPORTS | ANALYTICHEM INTERNATIONAL, INC. (US) | 1987-11-05 | — | — | WO | claimed |
| US-4578221-A | Androstane carbothioic acids | GLAXO GROUP LIMITED (GB) | 1986-03-25 | — | — | US | claimed |
| US-4224439-A | Activated matrix and method of activation | DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) | 1980-09-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250152693-A1 | Neisseria Meningitidis Vaccine | B3GNT2, MLEC, MAG | MGLL 385/4885FAAH 1371/4885ALDH1A1 3697/4885 |
| US-20250281590-A1 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF | C5AR1, C3AR1, C5 | MGLL 1152/4885FAAH 3073/4885ALDH1A1 2911/4885 |
| US-20250381259-A1 | Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof | CD44, CD47, FUT5 | MGLL 1182/4885FAAH 3970/4885ALDH1A1 3290/4885 |
| US-12624129-B2 | Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking thereof | CD44, MUC1, FGB | MGLL 2165/4885FAAH 752/4885ALDH1A1 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.